Address
Wellcome Trust
London
United Kingdom
Website
Recent investment activity
KANDO id: 31729
Corporate information
Registration country
Funding rounds
Investment preferences
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 29| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
|
Phononic Inc | Developer of solid-state technology for cooling and heating. | N/A Follow-on investment | |||
|
Siluria Technologies Inc | Maker of nanotechnology-enabled products for cleantech-related markets | Series C | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Castlight Health Inc | Series D | ||||
|
ABS Venture VII | Fund Closing | ||||
|
|
Siluria Technologies Inc | Maker of nanotechnology-enabled products for cleantech-related markets | Series B | |||
|
Wonga.com Ltd | UK-based provider of short-term cash advances. | Series C | |||
|
|
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series F | |||
|
|
Castlight Health Inc | Series C | ||||
|
|
Pacific Biosciences of California Inc | Provider of an integrated platform for genetic analysis. | Series E | |||
|
|
VaxInnate Inc | A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. | Series D | |||
|
|
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series C | |||
|
|
Lectus Therapeutics Ltd | N/A | ||||
|
|
Sirtris Pharmaceuticals Inc | Series C | ||||
|
|
Chroma Therapeutics Ltd | Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cance | Series C | |||
|
|
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series B | |||
|
|
Sirtris Pharmaceuticals Inc | Series B | ||||
|
|
Sirtris Pharmaceuticals Inc | Series A | ||||
|
|
Sirtris Pharmaceuticals Inc | Series A | ||||
|
TAE Technologies | N/A | ||||
|
|
Xtera Communications Inc | N/A | ||||
|
Achaogen Inc | Develops solutions to the problem of drug resistance | N/A Initial investment | |||
|
|
Intact Medical Corp | N/A | ||||
|
|
PTC Therapeutics Inc | Biopharmaceutical company. | N/A | |||
|
|
Cell Biosciences Inc | N/A | ||||
|
|
Sequoia Pharmaceuticals Inc | Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. | N/A |